Please monitor funder sites for all requirements, deadlines, and events as they are subject to change.
FUNDING OPPORTUNITIES - NEW
FUNDING OPPORTUNITIES - ONGOING
RESEARCH
AWARDS and HONOURS
EVENTS and ANNOUNCEMENTS
FUNDING OPPORTUNITIES - NEW
Alex's Lemonade Stand Foundation for Childhood Cancer: 2025 Young Investigator Grant
Internal deadline: December 3, 2024
External deadlines: December 12, 2024 7:59 PM (ET)
The Young Investigator grant is a three-year award designed to support early career researchers, such as postdoctoral fellows, clinical fellows or instructors, pursuing promising childhood cancer research ideas. These grants aim to cultivate the best and brightest researchers of the future who demonstrate a commitment to a research career in pediatric cancer. A mentor is required, and a career development plan must be included. The Young Investigator grant offers up to $60,000 in direct costs per year for three years.
More Information
American Association for Cancer Research: The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine
Internal deadline: December 5, 2024
External deadlines: December 10, 2024
The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine represents a joint effort to encourage and support postdoctoral or clinical research fellows to conduct highly novel and provocative research in the field of regenerative cancer medicine and to establish a successful career path in this field. The research proposed for funding may be translational, clinical, or epidemiological in nature and must have direct applicability and relevance to enhancing the physiology of cancer survivors (and/or mitigating the negative effects of their cancer treatment) using regenerative medicine approaches.
This award provides a two-year grant of $120,000 to support the salary and benefits of the fellow while working on mentored research focused on regenerative cancer medicine.
More Information
American Association for Cancer Research: The John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship
CLOI Internal deadline: December 17, 2024 1:00pm (EST)
CLOI External deadline: December 17, 2024 1:00pm (EST)
Internal deadline: March 25, 2025
External deadline: April 1, 2025 1:00 pm (EST)
The AACR-John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship encourages and supports postdoctoral and clinical research fellows to establish a successful career path in cancer research. The proposed project may be in any area of basic cancer research.
This fellowship provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on a mentored basic cancer research project. Research projects may be in any area of basic cancer research.
More Information
The Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion
CLOI Internal deadline: November 7, 2024 1:00pm (EST)
CLOI External deadline: December 4, 2024 1:00pm (EST)
Internal deadline: March 13, 2025
External deadline: March 20, 2025 1:00 pm (EST)
The Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion represent a focused effort to encourage and support investigators from diverse backgrounds who are underrepresented in cancer research and/or from low resource settings, and to foster their professional advancement. This grant program also intends to build a more diverse and inclusive future for breast cancer research. Eligibility is limited to members of racial or ethnic groups who have been shown to be traditionally excluded in the cancer related sciences workforce and/or to individuals from low resource settings.
Proposed project may be in basic, translational, clinical, epidemiological, population health, and/or community-based cancer related research and designed to accelerate the discovery, development, and application of new agents to treat breast cancer. Research that aims to advance the science of understanding cancer health disparities in racial and ethnic minorities with relevance to breast cancer will also be considered. The grants provide $150,000 over two years for expenses related to the research project
More Information
AACR-QuadW Foundation Sarcoma Research Fellowship in Memory of Willie Tichenor
Internal deadline: January 2, 2025
External deadline: January 9, 2025 1:00 pm (EST)
The AACR-QuadW Foundation Sarcoma Research Fellowship in Memory of Willie Tichenor represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct translational or clinical sarcoma research and to establish a successful career path in this field.
The fellowship provides a one-year grant of $60,000 to support the salary and benefits of the fellow while working on a mentored sarcoma research project.
More Information
American Association for Cancer Research - Johnson & Johnson Interventional Oncology Stimulating Therapeutic Advances through Research Training (START) Grants: Hematologic Malignancies Research Fellowship
Internal deadline: January 7, 2025
External deadline: January 14, 2025 1:00 pm (EST)
The AACR-Johnson & Johnson Interventional Oncology Stimulating Therapeutic Advances through Research Training (START) Grants represent an exciting initiative to address the need for promoting and supporting such collaborations. These grants, which will provide support to postdoctoral or clinical research fellows (please see eligibility criteria below), combine research experiences in both academic and industry settings, following a research timeline that will be of greatest benefit to the proposed work.
Each fellowship provides a three-year grant of $225,000 to support the salary and benefits of the fellow while working on a mentored cancer research project. Research proposals may be translational or clinical in nature but must have direct applicability to lung cancer. Proposals focused on mechanisms linking immunogenic cell death pathways to amplification of innate and adaptive immunity, immunobiology of non-small cell lung cancers, and mechanisms of acquired resistance to immunotherapies are highly encouraged.
More Information
American Association for Cancer Research: Hematologic Malignancies Research Fellowship
Internal deadline: January 14, 2025
External deadline: January 21, 2025 1:00 pm (EST)
AACR Hematologic Malignancies Research Fellowship represents an effort to encourage and support a postdoctoral or clinical research fellow to conduct basic, translational, clinical, or population sciences research projects focused on hematologic malignancies.
The fellowship provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on a mentored hematologic malignancies research project.
More Information
American Society of Nephrology – Pre-Doctoral Fellowship Award
Internal deadline: November 28, 2024
External deadlines: December 5, 2024
The goal of the KidneyCure Pre-Doctoral Fellowship Program is to fund PhD students to conduct original, meritorious research projects. This program will foster early career-stage PhD students, under the direction of a sponsor, who are highly motivated to make contributions to the understanding of kidney biology and disease.
The KidneyCure Pre-Doctoral Fellowship Program provides each nephrology pre-doctoral fellow with $30,000 per year for up to two years, to begin on July 1 of the award year.
More Information
American Head and Neck – 2025 Pilot Grant
Letter of Intent: December 16, 2024
Internal deadline: January 8, 2025
External deadline: January 15, 2025 11:59 pm (EST)
The purpose of this award is to support basic, translational, or clinical research projects in head
and neck oncology. Clinical or translational research studies are strongly encouraged and should be specifically related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neck neoplastic disease.
$20,000 maximum total (direct and indirect) costs over one year (non-renewable).
More Information
American Head and Neck Society - 2025 AHNS Presidential Awards
Letter of Intent: December 16, 2024
Internal deadline: January 8, 2025
External deadline: January 15, 2025 11:59 pm (EST)
Novel Therapeutic Targets and Combinations in Head and Neck Cancer
The purpose of this award is to support research projects that seek to identify novel therapeutic targets and combinations in head and neck cancer. Proposed studies may utilize genomics, immune profiling,
mechanistic approaches, human tissues (preferred) and/or animal models to identify novel therapeutic
targets in the tumor or microenvironment, based on biological dependencies. Each fellowship provides a 12 month award of $10,000. 10% indirect eligible expense.
More Information
Defining and Implementing Value-Based Care in Head and Neck Cancer
Research supported by this award should be specifically directed to Defining and Implementing ValueBased Care in Head and Neck Cancer ( see RFA online). Projects that demonstrate collaborative effort with members of other related disciplines are encouraged. Projects must be designed so as to yield useful information within the period of award, but priority will be given to projects that are also innovative with promise to develop into new long-range or expanded research programs capable of attracting funding from other sources.
Award provides a 12 month award of $10,000. 10% indirect eligible expense.
More Information
Understanding Treatment Resistance in Head and Neck Cancer
The purpose of this award is to support research projects that seek to understand mechanisms underlying resistance to therapy in head and neck cancer. Any study in head and neck cancer that utilizes genomics, immune profiling, mechanistic approaches, or animal models to understand how such mechanisms might develop and how we might predict the presence/absence of resistance phenotypes prior to treatment is eligible for this award.
Award provides a 12 month award of $10,000. 10% indirect eligible expense.
More Information
Thyroid Cancer Survivors’ Association for Thyroid Cancer Research
The purpose of this award is to support research projects that seek to understand mechanisms underlying resistance to therapy in head and neck cancer. Any study in head and neck cancer that utilizes genomics, immune profiling, mechanistic approaches, or animal models to understand how such mechanisms might develop and how we might predict the presence/absence of resistance phenotypes prior to treatment is eligible for this award.
Award provides a 12 month award of $10,000. 10% indirect eligible expense.
More Information
American Academy of Otolaryngology-Head and Neck Surgery Foundation - (AAO-HNSF) Bobby R. Alford Endowed Research Grant
Letter of Intent: December 16, 2024
Internal deadline: January 8, 2025
External deadline: January 15, 2025 11:59 pm (EST
The purpose of the American Academy of Otolaryngology-Head and Neck Surgery Foundation
(AAO-HNSF) Bobby R. Alford Endowed Research Grant is to support innovative research in the
specialty and help facilitate the career development of young investigators. This mentored research
award is intended to promote research that could ultimately lead to critical discoveries or major
advancements that will translate into improved understanding into the cause, treatment or outcome
for diseases of the head and neck
$30,000 maximum total (direct and indirect) costs over one year (non-renewable)
More Information
American Academy of Otolaryngology-Head and Neck Surgery Foundation - (AAO-HNSF) Maureen Hannley Research Grant
Letter of Intent: December 16, 2024
Internal deadline: January 8, 2025
External deadline: January 15, 2025 11:59 pm (EST
The purpose of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Maureen Hannley Research Grant is designed to fill “research gaps” identified by the AAO-HNSF clinical practice guideline panels. Research gaps listed by subspecialty are available at: https://www.entnet.org/resource/clinical-practice-guideline-research-ne…. Applicants are strongly encouraged to develop projects which address research gaps.
$30,000 maximum total (direct and indirect) costs over one year (non-renewable).
More Information
American Academy of Otolaryngology-Head and Neck Surgery Foundation - (AAO-HNSF) Resident Research Grants
Letter of Intent: December 16, 2024
Internal deadline: January 8, 2025
External deadline: January 15, 2025 11:59 pm (EST
The purpose of the AAO-HNSF Resident Research Grants are to stimulate original resident
research in otolaryngology projects that are well-conceived and scientifically valid, with the potential
to advance otolaryngology. One of the AAO-HNSF Resident Research Grants is being reserved to support a quality improvement and/or patient safety project.
Award provides a 12 month award of $10,000. 10% indirect eligible expense.
More Information
Canadian Cancer Society/University Health Network - Research Grants on Neurofibromatosis and Cancer: Probing the Links
Abstract deadline: December 11, 2024
Internal deadline: February 26, 2025
External deadlines: March 5, 2025
This program is a unique opportunity for cancer researchers to combine forces with researchers in neurofibromatosis and other relevant fields and disciplines to accelerate our understanding of the genomic and molecular drivers of cancer in NF1. The ultimate goal is to discover interventions to prevent cancer developing, or to enable diagnosis at the earliest possible time when treatments are likely to be more effective. In addition, projects focused on disease management and appropriate patient care, including the integration of clinical, translational, and technological innovations are strongly encouraged.
Maximum $200K/year or $400K in total over three years.
More Information
Canadian Cancer Society – 2025 Workplace Cancer Research Grants
Abstract deadline: January 8, 2025
Internal deadline: March 12, 2025
External deadlines: March 19, 2025
The CCS Workplace Cancer Research Grants have been created to support important and relevant cancer research that will uncover new knowledge and fill existing gaps related to a diversity of workplace cancer risk factors to inform cancer prevention efforts and the development of guidelines, policies, and regulations aimed at reducing cancer risk for workers in Canada.
Proposed projects must demonstrate a specific and defined potential for impact on the prevention of workplace exposures to risk factors, ultimately leading to a reduced incidence of workplace-related cancer.
Maximum $100K/year or $200K in total over two years.
More Information
CIHR - Master’s Award: Canada Graduate Scholarships
Internal deadline: November 20, 2024
University deadline:
Sponsor deadline: December 1, 2024 before 5:00 pm PT (8:00 pm ET).
The Canada Graduate Scholarships Master's Awards are intended to provide special recognition and support to students who are pursuing a Master's degree in a health related field at a Canadian institution. These candidates are expected to have an exceptionally high potential for future research achievement and productivity. Each applicant may apply to up to three eligible institutions in Canada. To be considered for a CGS M at UBC, applicants must fill out one of the "Proposed Host Organization" sections
Trainee stipend: $17,500 for 12 months, non-renewable
Applications from UBC to the CIHR Canada Graduate Scholarship - Doctoral (CGS D) Program are electronically submitted via ResearchNet by UBC Faculty of Graduate and Postdoctoral Studies.
UBC application information here.
SFU application information here.
Note that the application deadline is set at the national level and is not flexible; late applications cannot be submitted in the system and extensions to the deadline are not possible. Revisions to applications are not allowed once submitted.
More Information.
Cancer Research Society – 2025 Operating Grants Competition
Letter of Intent deadline: December 10, 2024
Internal deadline: February 4, 2025
External deadline: February 11, 2025 11:59 pm (EST)
The Cancer Research Society (CRS) is pleased to announce the launch of the 2025 Operating Grants competition. This program offers $135,000 over two years per grant to support fundamental and early translational cancer research across Canada. Open to both new and established researchers, it plays a crucial role in advancing cancer prevention, detection, and treatment.
The main applicant/PI must register at the CRS Research Portal, ProposalCentral, https://proposalcentral.com/GrantOpportunities.asp
More Information
Daiichi-Sankyo – Exploring protease inhibitors as therapeutic agent
Internal deadline: Past
External deadline: November 19, 2024
Daiichi-Sankyo established a proprietary platform for creating protease inhibitors that are highly potent and specific. Daiichi-Sankyo is seeking collaborations with researchers who have expertise in protease-related diseases, particularly those lacking effective treatments. In the collaborative research, Daiichi-Sankyo will create and provide inhibitors, and the collaborators are expected to advance the understanding of protease involvement in disease pathology and evaluate the therapeutic potential of protease inhibition.
More Information
Lung Cancer Canada – Give a Breath Research Award
Internal deadline: January 24, 2025
External deadline: January 31, 2025
Lung Cancer Canada is excited to announce the launch of the Give a Breath Research Award, an important new initiative aimed at driving forward innovative research into advanced lung cancer. This new annual research award has been made possible through the remarkable support of the Monds family and Give a Breath 5K. This year two awards are available at $25,000 each
The research focus of applications should revolve around advancements for patients with advanced or metastatic (i.e., stage III or IV) lung cancer; specifically, initiatives that apply to those beyond first-line therapy. Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, social, and population health research.
More Information
Lung Cancer Canda + Lung Cancer Alliance+ Astrazeneca Canada – Ambition Awards
Competition Opens: November 4, 2024
Internal deadline: January 31, 2025 ( or five business days in advance of submission)
External deadline: February 7, 2025
A joint initiative between Lung Cancer Canada, The Lung Ambition Alliance and AstraZeneca Canada, the Lung Ambition Awards are designed to support research that addresses key gaps in lung cancer care and improves the patient pathway. All Canadian clinicians and researchers working in the lung cancer space (across the multi-disciplinary spectrum) are encouraged to apply.
The program will grant $100,000 to research teams working to improve the lives of people with lung cancer.
More Information
Leukemia and Lymphoma Society - Specialized Center of Research (SCOR) Program
CLOI internal deadline: November 29, 2024
CLOI external deadline: December 6, 2024 3pm EST
Internal (Invited) deadline: March 24, 2025
External (Invited) deadlines: March 31, 2025
LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects.
The maximum total award is $5,000,000.00. The maximal total annual award is $1,000,000.00 for each year of the five-year grant. The maximum annual indirect cost is $150,000.00 (15% of total annual costs).
More Information
MSHRBC- CANTRAIN- CIHR: Clinical Research Internships
Internal deadline: a minimum of five (5) business days prior application submission to sponsor
External deadline: Accepted on a rolling basis until March 2025
Michael Smith Health Research BC partners with the Canadian Consortium of Clinical Trial Training (CANTRAIN), funded by the Canadian Institutes of Health Research, to help increase clinical trials training, expertise and capacity in BC and across Canada.
The internship program for clinical research professionals and new investigators is a unique opportunity. The program integrates online training with experiential, engaged learning opportunities and expert mentorship. Interns upgrade their skills and gain valuable experience in clinical trial activities outside their own institutions.
Six awards of up to $10,000 each are available to support BC-based individuals to intern at a Canadian-based clinical trials unit.
More Information
MSHRBC - 2025 – Health Professional-Investigator Program
Registration deadline: November 19, 2024
Internal deadline: January 16, 2025
External deadline: January 23, 2025 4:00pm Pacific Time
The Health Professional-Investigator Program supports health professionals who are actively involved in patient care to build their health research programs, train the next generation of scientists, and make significant contributions to their field.
$90,000/annum for salary support over five years.
More Information
MSHRBC - 2025 - Scholar Program
Registration deadline: November 19, 2024
Internal deadline: January 16, 2025
External deadline: January 23, 2025 4:00pm Pacific Time
The Scholar Program offers five-year awards to support researchers who are within six years from the start of their first appointment as independent investigators. Protects researchers’ time to conduct research, develop an independent research career, attract additional research funding, and train the next generation of researchers.
$90,000/annum for salary support over five years.
More Information
SU2C - with Johnson & Johnson: Catalyst Research Program
Registration deadline: November 19, 2024
Internal deadline: January 21, 2025
External deadline: January 28, 2025 11:59pm Pacific Time
The SU2C Catalyst Research Program with support from Johnson & Johnson endeavors to support a clinical trial involving combination teclistamab and daratumumab for the treatment of AL amyloidosis. Mechanisms to foster collaborations within and among the Team will be employed—an approach that promotes the sharing of information and a goal-oriented focus on measurable milestones of progress. SU2C believes that this unique Team will advance scientific research in the interests of improved long-term outcomes for patients.
Teams may apply for total support up to $2,000,000 over a 3-year term as well as supply for teclistamab and daratumumab. Indirect costs eligible to 25% of direct expenses. The full application to be submitted on ProposalCentral.
More Information
US- Dept of Defense – CDMRP: Pre-Announcements
Breast Cancer Research Program (BCRP)
- Breakthrough Award Levels 1 and 2
• Breakthrough Award Level 3
• Breakthrough Award Level 4
• Clinical Research Extension Award
• Era of Hope Scholar Award
• Transformative Breast Cancer Consortium Award
• Transformative Breast Cancer Consortium Development Award
To view the pre-announcement visit https://cdmrp.health.mil/pubs/press/2025/25bcrppreann)
FUNDING OPPORTUNITIES - ONGOING
American Association for Cancer Research: Career Development Award for Pancreatic Cancer Research, in Honor of John Robert Lewis
CLOI internal deadline: Past
CLOI external deadline: Past
Internal (Invited) deadline: January 2, 2025
External (Invited) deadlines: January 9, 2025
To support the development and diversity of talent working in pancreatic cancer research.
Amount: up to $300,000 USD Duration: up to 3 years
More Information
Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion
CLOI internal deadline: November 27, 2024
CLOI external deadline: December 4, 2024 1:00 p.m. U.S. Eastern Time
Internal ( invited) deadline: March 13, 2025
External (invited) deadline: March 20, 2025, at 1:00 p.m. U.S. Eastern Time
The Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and
Inclusion represent a focused effort to encourage and support investigators from diverse backgrounds
who are underrepresented in cancer research and/or from low resource settings, and to foster their
professional advancement. This grant program also intends to build a more diverse and inclusive future
for breast cancer research.
The grants provide $150,000 over two years.
More Information
Cancer Research Society & Leukemia & Lymphoma Society of Canada - Operating Grant
CLOI internal deadline: Past
CLOI external deadline: Past
Internal deadline: January 29, 2025
Application deadlines: February 5, 2025
The Cancer Research Society is partnering with the Leukemia & Lymphoma Society of Canada for their Operating Grant competition. Through this partnership, the Cancer Research Society (CRS) will co-finance 5 grants for innovative projects on blood cancers. Each grant offers funding of up to $200,000 over two years. We encourage researchers to submit their proposals and seize this opportunity to advance research in this critical area.
A letter of intent is required for all applications. Selected applicants will be invited to submit a full application.
More Information
CIHR - Other: Planning and Dissemination Grants – ICS 2024PCS
Internal deadline: Past
External deadline: November 19 , 2024
CIHR is offering planning and/or dissemination grants within the Institute/Initiative Community Support (ICS) Program. The Planning and Dissemination Grants are intended to provide support for planning and/or dissemination activities (either virtual or in-person) consistent with the mandate of CIHR and relevant to CIHR Institutes and Initiatives.
Each grant is for one (1) year. The maximum amount per grant varies by the sponsoring Institute and Initiative (see the Sponsor Description)
More Information
CIHR Undergraduate : Undergraduate Student Research Awards (USRA) Winter 2025
(Jan-Apr) 202405URS
Registration deadline: N/A
Internal deadline: a minimum of five (5) business days prior to Host Institution for CIHR deadline
Application deadline: January 15, 2025
Application deadlines:
Each eligible institution sets its own deadline dates for receiving applications. For information about these dates, contact the USRA liaison officer (LO) at the institution where you intend to apply for an award.
Although awards may be held in the summer, fall or winter term, each institution will determine the number of selection processes it holds each year.
The total amount available for this funding opportunity is $912,000, enough to fund approximately 152 awards. Award funding is allocated as follows: $6,000 plus host institution contribution.
More Information
Colorectal Cancer Alliance
Internal deadline: Minimum five (5) business days prior to external deadline
External deadline: Rolling – Inquire with Sponsor
The Colorectal Cancer Alliance (the Alliance) is pleased to announce a Request for
Proposals (RFP) for preclinical and clinical translational research with the
potential for high impact on diagnosis, treatment, or survivorship of colorectal
cancer.
Early-Career Investigator Award:
Early-Career Investigator Awards aim to attract early career faculty with original ideas into the field of colorectal cancer research, thereby recruiting and supporting the next generation of CRC research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Term: Two years Amount: Up to $100,000 per year for two years (up to $200,000 total) Eligibility Requirements:
Senior Investigator Award:
Senior Investigator Awards will fund potentially transformative ideas that will accelerate the translation of new therapies and technologies. Proposals may include investigator-initiated clinical trials and do not require IRB approval at the proposal stage. Collaborations are highly encouraged. Term: Two years Amount: Up to $1,000,000 per year for two years (up to $2,000,000 total
Pilot Award:
Pilot Awards support investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such "high-risk, high-reward" projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. Term: Two years Amount: Up to $100,000 per year for two years (up to $200,000 total).
Team Science Award:
The Team Science Award will support team science, including public-private partnerships, that will drive CRC research to curative science. Research proposals that accelerate new innovations from bench to bedside and address current unmet clinical needs will be prioritized. Term: Three years Amount: Up to $2,000,000 per year for three years (up to $6,000,000 total).
Awards can include indirect costs, overhead costs, or other similar institutional charges up to 5%
Please apply online via ProposalCENTRAL using the requirements therein
Email questions about this RFP, eligibility, or other issues about the Alliance or its awards to David
Fenstermacher, Senior Director of Research and Medical Affairs, dfenstermacher@ccalliance.org
Leukemia & Lymphoma Society of Canada (LLSC) - Blood Cancer Quality of Life Grant
CLOI internal deadline: Past
CLOI external deadline: Past
Internal ( invited) deadline: January 22, 2025
External (invited) deadline: January 29, 2025, at 4:00 p.m. U.S. Eastern Time
The intent of this funding opportunity is to support new research designed to address quality of life challenges experienced by Canadians affected by blood cancers. LLSC will provide funding up to a maximum of $75,000 per year for two years (up to a maximum total of $150,000 for the two years).
More Information
Leukemia & Lymphoma Society of Canada (LLSC) - Pediatric Blood Cancer Research Innovation Grant
CLOI internal deadline: Past
CLOI external deadline: Past
Internal ( invited) deadline: January 22, 2025
External (invited) deadline: January 29, 2025, at 4:00 p.m. U.S. Eastern Time
Pediatric Blood Cancer Research Innovation Grant - This grant is designed to challenge the current pediatric blood cancer landscape by providing funding for projects that will address unmet needs for pediatric blood cancers. The LLSC will provide funding up to a maximum of $100,000 per year for two years (up to a maximum total of $200,000 for the two years)
More Information
The Leukemia & Lymphoma Society Career Development Programs
Eligibility Deadline: Past
Letter of Intent External Deadline: Past
Internal Deadline - full application: Past
External Deadline full application: November 15, 2024, 3:00 PM (ET)
- The Fellow Award
- The Fellow award supports high quality postdocs who have clearly demonstrated productivity and critical thinking in their graduate studies as well as in their short time as a postdoc. Your graduate training need not have been in blood cancer. You must have 3 years or less of postdoctoral-level research training by the award start date. This award encourages you to embark on an academic career involving basic or translational research in hematologic malignancies and/or relevant premalignant conditions under a research mentor’s direction. This award is for 3 years and the maximum award per year is $70,000.
- Special Fellow
- The Special Fellow award supports postdocs and instructors having between 3 and 5 years of postdoctoral research training by the award start date, who have clearly demonstrated success in their current postdoctoral/instructor position, and who need an additional 2-3 years of training to be competitive for an independent position. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period. This award is for 2 or 3 years, depending on eligibility, and the maximum award per year is $75,000.
- The Scholar
- The Scholar award supports rising stars in the blood cancer research field. You must be a highly qualified investigator who has shown a capacity for independent, sustained, and original investigation in the field of hematologic malignancies and/or relevant pre-malignant conditions. This award is for 5 years and the maximum award per year is $120,000.
- Scholar in Clinical Research
- The Scholar in Clinical Research award supports rising stars in the clinical blood cancer research field. You must be a highly qualified investigator who holds an independent faculty-level appointment and is conducting independent clinical research, often involving early-stage clinical trials, that will advance the prevention, diagnosis, or treatment of hematologic malignancies and/or relevant pre-malignant conditions. The research should be related to your clinical activities and must directly involve patients. This award is for 5 years and the maximum award per year is $125,000.
More Information
Leukemia & Lymphoma Society (USA) -
Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups
CLOI Internal deadline: Past
Competitive Letter of Intent External deadline: Past
Internal deadline (full application by invitation): January 23, 2025
External deadline (full application by invitation): January 30, 2025
The purpose of this Request for Proposals (RFP) is to fund research studies that will increase our understanding of effective interventions for increasing accrual to therapeutic cancer clinical trials, particularly among underrepresented populations. Specifically, we seek proposals that will implement and evaluate interventions designed to a) mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups and b) quantitatively measure the impact of these interventions on patient accrual. We are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.
Maximum award amount $500,000 USD (inclusive of 11.1% indirect costs) over 5 years.
More Information
The Leukemia & Lymphoma Society – Discovery Grant Program (DPG)
Competitive Letter of Intent – Internal deadline: Past
Competitive Letter of Intent – External deadline: Past
Full Application Internal deadline: February 24, 2025, 10:00 am
Full Application External deadline: March 3, 2025, 3:00 PM ET
DGP is a research award program designed to encourage basic research, technological innovation, and informatics pipeline development. Also known as the Blood Cancer Discoveries Grant Program, DGP hopes to gain better understanding of blood cancer disease mechanisms, to help develop improved methods for detecting and monitoring cancer progression, and to help identify novel therapeutic targets.
The applicant (PI) must be an established investigator, defined as a researcher with more than 3 years in an independent faculty appointment at the time of submitting the Letter of Intent. Budget submitted should reflect the actual needs of the project but cannot exceed $250,000 USD per year / $750,000 USD total for the three (3) years of the grant.
This budget ceiling includes all costs associated with the grant including indirect costs (often referred to as Institutional Overhead), which will be capped at 10% of the total award.
More Information
Leukemia & Lymphoma Society (LLS) and The Institute for Follicular Lymphoma Innovation (IFLI) - Research Accelerator for Follicular Lymphoma (RAFL) Program
Competitive Letter of Intent – Internal deadline: Past
Competitive Letter of Intent – External deadline: Past
Full Application Internal deadline: January 6, 2025, 10:00 am
Full Application External deadline: January 13, 2025, 3:00 PM ET
Research will be aimed to understand the fundamental biology of FL progression, to develop new targets and therapies, and to launch clinical programs that can address the unmet FL patient needs. Ultimately, the overarching goal is to achieve a cure in which FL is eradicated, and therapy can be discontinued
- Synergistic Team Awards (STA) will support a coordinated, focused and significant effort to understand central disease mechanisms and develop effective novel therapies in treating FL. $6.5 M total award; $1.3M/yr for up to 5 years of funding
- Translational Awards (TRL) will support translational research that moves potential therapeutic candidates toward clinical trials within 2-3 years. Up to $1.75M total award; $350,000/yr for up to 5 years of funding. Indirect costs capped at 10% of total award amount.
More Information
Michael Smith Health Research BC-Mitacs Industry-Based Program
Registration Letter of Intent - deadline: December 1, 2024
Internal deadline: December 13, 2024 10:00 am
External deadline: December 20, 2024
The Michael Smith Health Research BC-Mitacs industry-based program supports graduate students and postdoctoral fellows across British Columbia to gain experience working within BC’s life sciences sector.
Through our partnership with Mitacs, the program offers industry-based placements through Mitacs Accelerate (for master and PhD students) and Elevate (postdoctoral fellows) programs.
Accelerate: Up to $90,000 per 24-month term | Elevate: Up to $129,000 per 24-month term.
More Information
National Institutes of Health
Various Competitions & Deadlines
Two Signature Packages are due if LOI is competitive.
Internal deadline: Five (5) business days prior to external deadline
Grants.gov Internal deadline: at least two (2) business days prior to external deadline
External deadline: Various - by 5:00 PM local time
Search grants.gov for current opportunity announcements and deadlines.
The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH. Standard due dates for new applications are February 5, June 5, and October 5.
The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.
More Information
Pfizer Inc. – Oncology Areas of Interest - Research Grants
Internal deadline: Five (5) business days prior to external deadline
External deadline: Various
Qualified researchers are invited to submit investigator-sponsored research (ISR) proposals, according to the guidance and instructions found on the Pfizer ISR portal at www.Pfizer.com/ISR. All proposals must be submitted via the ISR submission portal. An ISR proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for ISR submissions are made by the applicable Pfizer Global Review Committee.
Oncology compounds are listed here. For each compound, the areas of interest are listed in order of medical and scientific unmet need.
The Oncology ISR Program has implemented application windows for unsolicited requests. Please click here to view the Quarterly Application and Review Cycles.
More Information
Radiological Society of North America - Grant Opportunities
RSNA members are eligible to apply for grants in the following areas.
Research Scholar Grant
Resident/Fellow Research Grant
Research Seed Grant
Internal deadline: January 17, 2025
External deadline: January 24, 2025
Medical Student Research Grant
Internal deadline: January 31, 2025
External deadline: February 7, 2025
More Information
The Rivkin Center for Ovarian Cancer Research – Pilot Study Grants
Internal deadline: November 26, 2024
External deadline: December 2, 2024 at 5pm EST
These grants provide seed funding for new scientific explorations. By funding innovative ideas globally, we pave the way for breakthroughs in ovarian cancer research. $75,000 over 2 years
More Information
UBC: Killam Faculty Research Fellowships
Internal deadline: Past
Application deadlines: November 15, 2024
Description: to assist promising faculty members, who wish to devote full time to research and study in their field during a recognized study leave.
Amount: up to $18,000 Duration: up to 1 year
More Information
US-Department of Defense – Glioblastoma Cancer Research Program (GBMRP)
Resource Development Award
Hypothesis Development Award (wither Partnering Principal Investigator Option)
Pre-Application Registration Deadline: Past
Internal Deadline: Past
Online Upload Deadline: November 18, 2024 10:00am PST
External Deadline: November 20 ,2024
More Information
AWARDS AND HONOURS
The Canadian Cancer Society Awards for Excellence
Internal deadline: n/a
External deadline: December 11, 2024
The Canadian Cancer Society Awards for Excellence in cancer research recognize individuals who have made, and are making, valuable contributions to the cancer research ecosystem in Canada. Recipients are leaders in their fields who exemplify excellence in science and outstanding service to the scientific community. Posthumous nominations are not eligible.
Recipients will be recognized and will receive a personalized glass plaque commemorating their award. Each award also comes with a $20,000 contribution to the recipient’s research program.
More Information
AACR-CIHR Scholar-in-Training Awards (SITAs)
Internal deadline: N/A
Application deadline: November 26, 2024 at 11:59 PM EST.
The CIHR Institute of Cancer Research (ICR) has partnered with the American Association for Cancer Research (AACR) to launch the inaugural AACR-CIHR Scholar-in-Training Awards (SITAs)to support PhD students, postdoctoral fellows, and post-health degree fellows to attend and present their research at the AACR Annual Meeting 2025, the world’s largest cancer research conference.
Submit an online application form using the AACR portal. Applications from all areas of cancer research are encouraged.
More Information
Charles A. McDowell Award at UBC
Internal deadline: n/a
External deadline: November 15,2024
The award, consisting of a medal and a certificate, will be made to an outstanding early career member of the faculty of UBC who has demonstrated excellence in pure or applied scientific research.
More Information
Yale University – Gruber Prize
Internal deadline: n/a
External deadline: December 15,2024
The Gruber Foundation invites nominations on behalf of individuals whose achievements in Cosmology, Genetics, or Neuroscience would make them suitable candidates for recognition through the Gruber International Prize Program.
Each prize, which is accompanied by a $500,000 unrestricted monetary award, is designed both to recognize groundbreaking work in each field and to inspire additional efforts that effect fundamental shifts in knowledge and culture. Recipients are selected by a committee of distinguished experts in each field.
More Information
Jacob Biely Faculty Research Prize at UBC
Internal deadline: n/a
External deadline: November 15, 2024
The prize, comprised of $3,000 and a certificate, is awarded annually to a full-time tenure-stream UBC faculty member in recognition of a distinguished record of research that has contributed substantially to UBC’s stature as a leading research institution.
More Information
Killam Postdoctoral Fellow Research Prizes at UBC
Internal deadline: n/a
External deadline: December 4 ,2024 10:00 AM PST
Killam Postdoctoral Fellow Research Prizes are awarded annually for excellence in research. Established in 2011, the Killam PDF Prize is in memory of Izaak Walton Killam and his wife, Dorothy Johnston Killam, who together created the Killam trusts. Two prizes in the amount of $5,000 each are awarded to fulltime Postdoctoral Fellows at UBC in recognition of outstanding research and scholarly contributions while at UBC.
Nominations for the Killam PDF Prize are made to the Dean's Office of their appointing faculty, and faculties submit their nominations to the PDFO. Eligibility, procedures and deadlines can be found on the PDFO website.
EVENTS AND ANNOUNCEMENTS
BC Cancer Ethics Office - December Hours Update
The BC Cancer Research Ethics Office will be closed December 23rd – December 27th. For any ethics related questions please email: reb@bccancer.bc.ca
NIH - Research Performance Progress Reports (RPPR) Updates
Effective for Research Performance Progress Reports (RPPR) due on or after October 1, 2024, a set of new questions has been added, asking NIH recipients for details on how they are adhering to their approved Data Management and Sharing (DMS) Plan, if applicable.
Note that RPPR users who have initiated but not submitted their RPPR as of October 1, 2024, may need to redo the revised C.5 section, which will be split into C.5.a (Other Products), C.5.b (Resource Sharing) and the new C.5.c (DMS) section under the C. Products section.
See NIH Guide Notice: NOT-OD-24-175, NOT-OD-24-176 and NOT-OD-24-123 as well as DMS Policy
UBC Faculty of Medicine Data Management Day
At this exciting hybrid event, you'll discover innovative data management solutions driving healthcare research across the Faculty of Medicine.
Date & Time: November 19; 8:30am–12:00pm PT
Location: Eye Care Centre's Lecture Theatre on the Vancouver General Hospital Campus or virtually via Zoom (RSVP here)
This email lists some of the most commonly accessed funding mechanisms at BC Cancer and their associated deadlines. The listing is maintained by the Office of Research Administration. If you can not find information on a particular Funding Announcement, please contact a Grants Officer at ORA. While ORA has made every attempt to ensure that the information contained in this listing has been obtained from reliable sources, the Office of Research Administration is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this email is provided "as is", with no guarantee of completeness, accuracy, timeliness. Sponsor requirements and deadlines are subject to change. It is the applicant's responsibility to stay current with any changes in the funding opportunity requirements. The information contained in this email is intended solely to provide general guidance on BC Cancer internal deadlines & Sponsor external deadlines.
Please note that all applications/co-applications/proposals/competitive letters of intent are to be approved by The Office of Research Administration (ORA) using a BC Cancer Research Coversheet and accompany a copy of the application signature package for ORA records. Applicants are advised to allow a minimum of five (5) for processing. NOTE: The ORA signature package is required prior to eSubmission or paper submission of the application by the applicant to the funding agency regardless of whether or not an institutional signature is required by the Sponsor/Funder.
Contact the OFFICE OF RESEARCH ADMINISTRATION:
BC Cancer
Office of Research Administration
675 West 10th Avenue, Vancouver, BC
604-675-8251
khagan@bccancer.bc.ca